Overview

ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach

Status:
COMPLETED
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
Determine ED50 dexmedetomidine adjuvant that can provide spinal anesthetic sensory blockade duration of 200 minutes on knee and pelvis surgery with up-and-down method.
Phase:
NA
Details
Lead Sponsor:
Indonesia University
Treatments:
Dexmedetomidine